long-term survival outcomes in pts with mf treated with momelotinib vs danazol in the momentum trial
Published 4 months ago • 55 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
1:11
genetic dynamics and factors predictive of survival in relapsed aml
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
8:34
hct in mds: cell source and conditioning type
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:57
combining molecular and clinical data to predict survival & transformation risk in patients with mds
-
3:40
master class in transplantation and hematology: highlights
-
2:10
updated overall survival data on eltanexor for hma-refractory mds
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
1:36
relative dose intensity in older dlbcl patients
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:41
isct in bringing together the scientific community
-
8:57
outcomes of sct in t-all and t-lbl
-
3:04
applying molecular understanding of dlbcl to management strategies
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024
-
1:28
use of machine learning to predict outcomes for patients with scd
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
2:20
ultra high-risk myeloma
-
6:28
outcomes following first-line therapy in routine clinical practice in alcl